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Conclusion: This study identiﬁed a combination of clinical
parameters that can be used to characterize early onset of
disease following a low dose A/Vietnam/1203/04 challenge.338 14
istology Clinical Isolate SV068 Hematoxilin Eosin 60 days
Conclusion: Our preliminary ﬁndings suggest that the host
efense can vary accordingly to the type of clinical isola-
ion, leading to a correlation between the virulence and the
ource of infection.
oi:10.1016/j.ijid.2010.02.370
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valuation of the ferret as a model for inﬂuenza
/Brisbane/10/07 H3N2
. Garver1,∗, K. Van Zandt2, J. Rhone2, G. Stark2, J. Bigger2
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Background: During the 2008-2009 inﬂuenza season, an
utbreak of the H3N2 A/Brisbane/10/07 strain occurred in
everal European countries. Great Britain experienced its
orst inﬂuenza outbreak in eight years. Further, the World
ealth Organization (WHO) reports that inﬂuenza seasons
n which H3N2 strains are predominate have been asso-
iated with a greater risk of severe illness and mortality
ates. Thus, the need for effective vaccines and therapeutics
gainst interpandemic inﬂuenza strains remains a high prior-
ty. To provide an appropriate animal model for these novel
roducts, the ferret was evaluated as a possible efﬁcacy
odel for Inﬂuenza A/Brisbane/10/07 H3N2.
Methods: Forty-eight male ferrets were divided among 8
roups. Four groups of 8 ferrets were infected with approx-
mately 1x106 TCID50/mL of A/Brisbane/10/07 in the nasal
avity. Sham control groups of 3 ferrets each were inocu-
ated with allantoic ﬂuid produced in embryonated chicken
ggs and CMF-PBS. The ferrets were monitored for signs of
nfection by clinical observation, changes in weight and tem-
erature, detection of viral shedding in nasal washes, and
eroconversion as determined by microneutralization assay.
Results: All animals survived infection with only mild
igns of illness. Weight loss was generally not observed
fter infection. Instances of febrility (deﬁned as greater
han two standard deviations from the baseline tempera-
ure) were present in some animals and persisted through
he end of the study. Viral load in the nasal wash was present
t 16 hours post-challenge. Nasal washes collected 24 to
2 hours post-challenge demonstrated an increased titer of
to 2 logs from the previous time-points, while samples col-
ected 96 to 120 hours post-challenge exhibited a decrease
dternational Congress on Infectious Diseases (ICID) Abstracts
n titer. Pre-challenge sera tested by the microneutraliza-
ion assay (MN) lacked detectable neutralizing antibodies
gainst A/Brisbane/10/07, however sera collected at the
tudy end-point displayed a discernible increase in neutral-
zing antibody titer.
Conclusion: The most reliable indications of infection for
n individual animal were viral recovery from nasal washes
nd observation of sneezing or coughing.
oi:10.1016/j.ijid.2010.02.371
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atural history study of a low dose HPAI
A/Vietnam/1203/04) infection in ferrets
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Background: The objective of this study was to reﬁne a
ow dose ferret therapeutic model of A/Vietnam/1203/04
nﬂuenza infection.
Methods: Forty-four male ferrets (Mustela putorius
uro), 8—15 weeks in age, were divided into 4 groups of
ferrets (groups A, C, E and G; experimental) and 4 groups
f 3 ferrets (groups B, D, F and H; controls). Animals in
roups A, C, E and G were challenged with 5 x 103 TCID50
f A/Vietnam/1203/04 via the intranasal route. Data col-
ection was staggered by group pairs (groups A+B, C+D, E+F,
+H) so that clinical observations, blood (clinical hematol-
gy and clinical chemistry), nasal wash specimens (qPCR and
CID50), and temperature data were collected at approx-
mately 8 hour intervals from 16-48 hours and at 24 hour
ntervals between 72 and 120 hours. After 120 hours, tem-
eratures and clinical observations were recorded 2 times
aily until the end of the study (Day 14) or death of the ani-
al. Tissues were collected from any infected animal found
ead or euthanized prior to day 14, for determination of
iral load by a combination of qPCR and TCID50.
Results: All animals challenged with A/Vietnam/1203/04
uccumbed. Observations for infected animals included: 1)
igniﬁcant decreases in body weight on all study days, 2)
igniﬁcant increases in body temperature as early as 1 day
ost-challenge, and 3) signiﬁcant changes in clinical activ-
ty beginning at 40 hours. Analysis of clinical hematology
ata for peripheral blood specimens revealed signiﬁcant dif-
erences between control and infected animals as early as
2—48 hours post-challenge for lymphocytes, white blood
ells, and platelets. Signiﬁcant persistent clinical chemistry
arameter changes were limited to serum glucose, albumin,
alcium and phosphorous. Results of TCID50 assays and qPCR
emonstrated virus shedding in nasal wash specimens as well
s high viral titers in a number of tissues (brain, olfactory
ulb, liver, lung, and nasal turbinates).oi:10.1016/j.ijid.2010.02.372
